8i 8i 8i 8i 8i
8i Questions with Answers () (Verified 8i 8i 8i 8i 8i 8i
8i Answers)- Chamberlain. 8i
1. During what trimester is a pregnant woman most at risk for adverse drug
8 i 8 i 8 i 8 i 8 i 8 i 8 i 8 i 8 i 8 i 8 i 8 i
reactions with potential long term consequences?
8i 8i 8i 8i 8i 8i
Answer: 1st trimester (fetus most at risk d/t rapid growth)
8i 8i 8i 8i 8i 8i 8i 8i 8 i
2. What is BEERS criteria?
8i 8i 8i
Answer: Recommendations of medications inappropriate for elderly (65 and older), prescriber ultimately decides
8 i 8 i 8 i 8 i 8 i 8 i 8 i 8 i 8 i 8 i 8i 8i
3. What is the CYP450 (cytochrome P450)
8i 8 i 8 i 8 i 8 i
Answer: liver enzyme system where medications are metabolized, can either be inducers or inhibitors and create drug-
8i 8i 8i 8i 8i 8i 8i 8i 8i 8i 8i 8i 8i 8i 8i 8i
drug interactions
8i
4. CYP450 inducers 8 i
Answer: Speed up metabolism of drugs (drug is cleared faster), drug has lesser ettect (decrease blood levels of drug),
8 i 8i 8i 8i 8i 8i 8i 8i 8i 8i 8i 8i 8i 8i 8 i 8i 8i 8i
elevate CYP450 enzymes
8 i 8i 8i
5. CYP450 inducers pneumonic Answer: "Bullshit Crap GPS INDUCES rage"
8 i 8 i 8 i 8 i 8i 8i 8i 8i
mailto:https://www.stuvia.com/user/Wisdoms
, 6. CYP450 inducer drug names 8i 8i 8i
Answer: Barbituates, St John wort, Carbamazepine, rifampin, alcohol, phenytoin, griseofulvin, phenobarbital,
8 i 8 i 8i 8 i 8i 8 i 8 i 8 i 8 i 8i
sulfonylureas
8i
7. CYP450 inhibitors Answer: inhibit metabolism, increase blood levels of medications
8 i 8i 8 i 8i 8i 8i 8i 8i 8i
8. CYP450 pneumonic Answer: "VISA credit card debt INHIBITS spending on designers like CK to look GQ"
8 i 8i 8 i 8i 8i 8i 8i 8i 8i 8i 8i 8i 8i 8i 8i
9. CYP450 inhibitors drug name Answer s: Valproate, isoniazid, sulfonamides, amiodarone, chloramphenicol,
8i 8i 8i 8i 8i 8i 8i 8i 8i 8i
ketoconazole, grapefruit juice, quinidine
8i 8i 8i 8i
10. Physiological changes during pregnancy that impact pharmacodynamics 8 i 8 i 8 i 8 i 8 i 8 i
8 and pharmacokinetic properties of drugs?
i 8i 8i 8i 8i
Answer: increase glomerular filtration rate leads to increase durg excretion
8 i 8i 8i 8i 8i 8i 8i 8 i 8i
increase hepatic metabolism decrease
8i 8i 8i
tone and motility of bowel increase drug
8i 8i 8i 8i 8i 8i 8i
absorption
8i
11. Examples of medications that can be teratogenic 8i 8i 8i 8i 8i 8i
Answer: Antiepileptic drugs, antimicrobials such 8 i 8i 8i 8i
as tetracyclines and fluoroquinolones, vitamin A in large doses, some anticoagulants, and hormonal medications suchas diethylstilbestrol
8i 8i 8i 8i 8i 8i 8i 8i 8i 8i 8i 8i 8i 8i 8
i 8i
(DES).
8i
12. How is absorption of intramuscular medications different in neonates?
8i 8i 8i 8i 8i 8i 8i 8i
Answer: slow 8 i
and erratic due to low blood flow in muscles first few days of life
8i 8i 8i 8i 8i 8i 8i 8i 8i 8i 8i 8i 8i
13. Whyis absorption of medication in thestomach increased in infancy?
8i 8i 8i 8i 8i 8i 8i 8i 8i 8i
mailto:https://www.stuvia.com/user/Wisdoms
, Answer: delayed gastric emptying
8 i 8 i 8i
14. Some medications that shouldbe avoided in the pediatricpatient?
8i 8i 8i 8i 8i 8i 8i 8i 8i
Answer: glucocorti- coids, discoloration of developing teeth with tetracyclines, and kernicterus with sulfonamides,
8 i 8 i 8 i 8 i 8 i 8 i 8 i 8 i 8 i 8 i 8 i 8 i
levofloxacin (antibiotics) aspirin (Severe intoxication from acute overdose)
8 i 8i 8i 8i 8i 8i 8i 8i
mailto:https://www.stuvia.com/user/Wisdoms
, 15. what should be included in medication administration patient education?: 8 i 8 i 8 i 8 i 8 i 8 i 8 i 8 i
8 i - dosage size and timing
8 i 8i 8i 8i
route and technique of administration duration of
8i 8i 8i 8i 8i 8i
treatment
8i
drug storage 8i
nature and time course of desired responses 8i 8i 8i 8i 8i 8i
nature and time course of adverse responses
8i 8i 8i 8i 8i 8i 8i
finish taking antibiotic
8i 8i 8i
16. What are some things that put the elderly patient at higher risk for 8 i 8 i 8 i 8 i 8 i 8 i 8 i 8 i 8 i 8 i 8 i 8 i
adverse drug reactions?: reduced renal function polypharmacy
8 i 8i 8i 8i 8i 8i 8i
(theuseoffive ormoremedicationsdaily) greaterseverityof illness
8
i 8
i 8
i 8i 8
i 8
i 8
i 8 i 8
i 8i 8i
presence ofcomorbidities 8i 8i
use of drugs that have a low therapeutic index (e.g., digoxin) increased individual
8i 8i 8i 8i 8i 8i 8i 8i 8i 8i 8i 8i
variation secondary to altered pharmacokinetics inadequate supervision of
8i 8i 8i 8i 8i 8 i 8i 8i
long-term therapy
8i 8i
poor patient adherence 8 i 8 i
17. How can healthcare providers decrease likelihood of an elderly patient expe- riencing an
8i 8i 8i 8i 8i 8i 8i 8i 8i 8i 8i 8i
8 adverse drug reaction?: obtaining a thorough drug history that includes over-the-counter medications
i 8i 8i 8 i 8i 8i 8i 8i 8i 8i 8i 8i
considering pharmacokinetic and pharmacodynamics changes due to age monitoring
8i 8i 8i 8i 8i 8i 8i 8i
8 the patient's clinical response and plasma drug levels
i 8i 8i 8i 8i 8i 8i 8i
mailto:https://www.stuvia.com/user/Wisdoms